Graycell Advisors publishes stock portfolios using quantitative-driven models and systematic investing. For 2016, Graycell Smallcap Portfolio was up +71% compared to benchmark Russell 2000 Index gain of +9%. All Seeking Alpha articles under Graycell Advisors are written by Tarun Chandra, who has prior experience as an Equity Analyst on the Sellside and Buyside, as well as experience in Corporate Strategy and Finance. More Seeking Alpha articles can be viewed under the 2nd ID, Tarun Chandra, CFA, where we publish mostly on Biotech. In addition, we have a Graycell Blog and a Prudent Biotech Blog for more updated coverage. We invite you to take a look at the Performance, Samples, and Philosophy, and decide for yourself if the Small Cap and Biotech products can contribute to your investment objectives. You can even view Samples, Register for a Free Pick from the Portfolio, and check the risk-free subscription with a 2-month money back guarantee. Nothing here or on the site constitutes a personalized investment recommendation, and stocks mentioned in the reports/articles/comments may be now or in the past, part of the portfolios recommended by Graycell Advisors and related entities. Graycell Advisors and related entities are not a Registered Investment Advisor (RIA). Any questions, please write to Support @ GraycellAdvisors.com
Sophocles, a Fulbright scholar and Chartered Financial Analyst, has over 15 years experience in the global financial markets. He manages institutional money based on his personal investment strategy (known as FatAlpha). He spent over 11 years at an award-winning London-based emerging markets hedge fund while was previously employed in the brokerage and investment banking industry. A strong believer in value investing, Sophocles is passionate about the markets and his pursuit of investment alpha. His strategy consists of combining quantitative models with his own qualitative analysis. Sophocles graduated from the University of Illinois at Urbana-Champaign with a double major in Economics and Finance.